This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Makoto Haruta: Innovator in Histone Acetyl Transferase Inhibition
Introduction
Makoto Haruta is a distinguished inventor based in Yachiyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit histone acetyl transferase activity.
Latest Patents
Haruta holds a patent for an EP300/CREBBP inhibitor. This invention provides a compound that exhibits excellent histone acetyl transferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by a specific formula, which enhances its potential therapeutic applications.
Career Highlights
Haruta is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the understanding and treatment of various diseases.
Collaborations
Some of his notable coworkers include Hiroyuki Naito and Yoshiko Kagoshima. Their collaborative efforts have further enriched the research environment at Daiichi Sankyo Company, Limited.
Conclusion
Makoto Haruta's contributions to the field of histone acetyl transferase inhibition exemplify the impact of innovative research in biochemistry. His work continues to pave the way for advancements in therapeutic solutions.